Literature DB >> 7890710

Characterization of the Elk-1 ETS DNA-binding domain.

P Shore1, L Bisset, J Lakey, J P Waltho, R Virden, A D Sharrocks.   

Abstract

The ETS domain family of transcription factors is comprised of several important proteins that are involved in controlling key cellular events such as proliferation, differentiation, and development. One such protein, Elk-1, regulates the activity of the c-fos promoter in response to extracellular stimuli. Elk-1 is representative of a subgroup of ETS domain proteins that utilize a bipartite recognition mechanism that is mediated by both protein-DNA and protein-protein interactions. In this study, we have overexpressed, purified, and characterized the ETS DNA-binding domain of Elk-1 (Elk-93). Elk-93 was expressed in Escherichia coli as a fusion protein with glutathione S-transferase and purified to homogeneity from both the soluble and insoluble fractions using a two-column protocol. A combination of CD, NMR, and fluorescence spectroscopy demonstrates that Elk-93 represents an independently folded domain of mixed alpha/beta structure in which the three conserved tryptophans appear to contribute to the hydrophobic core of the protein. Moreover, DNA binding studies demonstrate that Elk-93 binds DNA with both high affinity (Kd approximately 0.85 x 10(-10)M) and specificity. Circular permutation analysis indicates that DNA binding by Elk-93 does not induce significant bending of the DNA. Our results are discussed with respect to predictive models for the structure of the ETS DNA-binding domain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890710     DOI: 10.1074/jbc.270.11.5805

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1.

Authors:  S H Yang; E Vickers; A Brehm; T Kouzarides; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy.

Authors:  Yael Gernez; Rabindra Tirouvanziam; Grace Yu; Eliver E B Ghosn; Neha Reshamwala; Tammie Nguyen; Mindy Tsai; Stephen J Galli; Leonard A Herzenberg; Leonore A Herzenberg; Kari C Nadeau
Journal:  Int Arch Allergy Immunol       Date:  2010-10-25       Impact factor: 2.749

3.  Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1.

Authors:  S H Yang; A J Whitmarsh; R J Davis; A D Sharrocks
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

4.  Determinants of DNA-binding specificity of ETS-domain transcription factors.

Authors:  P Shore; A J Whitmarsh; R Bhaskaran; R J Davis; J P Waltho; A D Sharrocks
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.

Authors:  S H Yang; A Galanis; A D Sharrocks
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif.

Authors:  S H Yang; P R Yates; A J Whitmarsh; R J Davis; A D Sharrocks
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

7.  Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.

Authors:  Claire A P Bristow; Paul Shore
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

8.  The ETS-domain transcription factors Elk-1 and SAP-1 exhibit differential DNA binding specificities.

Authors:  P Shore; A D Sharrocks
Journal:  Nucleic Acids Res       Date:  1995-11-25       Impact factor: 16.971

9.  Differential gene expression between developing queens and workers in the honey bee, Apis mellifera.

Authors:  J D Evans; D E Wheeler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells.

Authors:  Rajash Pallai; Aishwarya Bhaskar; Valerie Sodi; Lyndi M Rice
Journal:  Transcription       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.